Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
about
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentCreatine for women in pregnancy for neuroprotection of the fetusCreatine for Parkinson's diseaseCreatine for Parkinson's diseaseThe role of oxidative stress in Parkinson's diseaseNutraceuticals in Parkinson's DiseaseA review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditionsOxidative Stress in Neurodegenerative DiseasesCreatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancyMitochondrial dysfunction and oxidative stress in Parkinson's diseaseAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewMitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes.C. elegans S6K Mutants Require a Creatine-Kinase-like Effector for Lifespan ExtensionThe diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.Brain imaging and human nutrition: which measures to use in intervention studies?Potential future neuroprotective therapies for neurodegenerative disorders and stroke.The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trialsInternational Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicineA potential role for creatine in drug abuse?Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.Stuck at the bench: Potential natural neuroprotective compounds for concussion.Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Does creatine supplementation improve the plasma lipid profile in healthy male subjects undergoing aerobic training?Progress in neuroprotection in Parkinson's disease.Protection against Parkinson's disease progression: clinical experience.Therapy development for ALS: lessons learned and path forward.Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson's disease.Targets for neuroprotection in Parkinson's diseaseMitochondrial approaches for neuroprotectionRole of creatine supplementation on exercise-induced cardiovascular function and oxidative stress.Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.Creatine in mouse models of neurodegeneration and aging.
P2860
Q22241837-A24DC273-D8A9-437A-A483-2B74F909CA45Q24187191-D1A526AF-59CF-44F4-A6B0-ECC9B3C11DEFQ24193947-C536E8B4-417A-4805-90A8-5EA831698988Q24203799-7864BECE-9BE8-4A17-9191-A2CF9F4BAAA9Q24307946-42C9641B-6C5B-4FE9-81D6-F3C7E97F84ACQ26752769-56319083-3A88-49DC-9244-4DAF0209C93AQ26781560-C79C9830-1B95-47D6-B805-594DD96326DDQ26801239-E3068D12-ADA2-4B18-81DB-0415ADD1A9CDQ27006952-C82E61F7-C325-4226-917C-9E2545FC2FE7Q27014051-2959A1E4-EC85-4C78-82F7-CA6A1E22DF93Q28084254-712E2191-0A57-4479-B080-C50B9970EC8AQ28386769-227F2293-D03F-47D3-A22E-C215F596D872Q28601083-C8281B96-06B6-43D5-A026-C055AE552E73Q30635471-6C68B8AE-F95C-49CE-9305-CF3602B9B360Q30658391-F508E6D7-D3B3-4F38-9F83-9379C64A4568Q33687436-AB9526BB-EAA8-47A0-B050-81888DF22C59Q33760040-B71E20AA-6834-4F87-8D5C-B8F6C98BA9BFQ33791877-E89FB048-020D-463F-91D1-117472BE5125Q33844763-87D7616B-2725-4C21-9D2F-C0D769F521A4Q34089086-94775B22-5BFC-47F3-8304-61575BE9183AQ34460675-81DF80B6-0642-42D7-96F2-46A3CEF7E046Q35045060-51F2A8C8-D398-4A41-8BF4-CDFD599BFA47Q35493114-5DC1C675-3B4F-4170-A8F2-55BCEB6EB0DAQ35642539-BC5E63E5-D967-48CE-AA77-A5F7714B13B7Q35958359-84327652-DD73-49CF-841F-37DF4380ADFDQ36499640-DD555E1E-99B4-4AE8-8D8F-C4C1C25E7FC7Q36975082-2D9328E2-4422-4A34-B48E-6E98058401DCQ37114112-EB6485FE-D97C-4370-971A-923EC7B53549Q37131239-8884E376-5F29-46D1-A9E1-6D866A2216C5Q37198692-EE8B8790-38FA-4690-9AD4-BF6B8E988C92Q37298397-8843D696-04FB-4FE3-840F-515FB7FAC49FQ37302453-CB0E635E-74A6-4D18-A6A2-3B15C44232C2Q37348590-63962534-F41C-4151-9675-B6DE4FFE7E9DQ37390314-DC564C6A-CBCB-41D5-BF4F-2B4DC7BED270Q37506492-C75D529D-D804-40DD-970F-782A765B8FE8Q37539279-BCECA6FC-BAD7-40DA-83A9-3F8FE38906D5Q37580731-1507D214-DB57-4EA2-BE02-B08E18FA2315Q37653023-1E3475B8-B4EE-4201-B942-D10B69202912Q37698597-3FFFA1AA-229D-4E66-B3A7-C1885A25AD9AQ37851389-9ED3124E-82C4-414A-8554-56F3B0B5C7C2
P2860
Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@en
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@nl
type
label
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@en
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@nl
prefLabel
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@en
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@nl
P2093
P1433
P1476
Creatine supplementation in Pa ...... rolled randomized pilot trial.
@en
P2093
Klopstock T
Müller-Myhsok B
Schombacher Y
P304
P356
10.1212/01.WNL.0000238518.34389.12
P407
P577
2006-10-01T00:00:00Z